Expression-Based Genome-Wide Association Study Links Vitamin D–Binding Protein With Autoantigenicity in Type 1 Diabetes

Type 1 diabetes (T1D) is caused by autoreactive T cells that recognize pancreatic islet antigens and destroy insulin-producing β-cells. This attack results from a breakdown in tolerance for self-antigens, which is controlled by ectopic antigen expression in the thymus and pancreatic lymph nodes (PLNs). The autoantigens known to be involved include a set of islet proteins, such as insulin, GAD65, IA-2, and ZnT8. In an attempt to identify additional antigenic proteins, we performed an expression-based genome-wide association study using microarray data from 118 arrays of the thymus and PLNs of T1D mice. We ranked all 16,089 protein-coding genes by the likelihood of finding repeated differential expression and the degree of tissue specificity for pancreatic islets. The top autoantigen candidate was vitamin D–binding protein (VDBP). T-cell proliferation assays showed stronger T-cell reactivity to VDBP compared with control stimulations. Higher levels and frequencies of serum anti-VDBP autoantibodies (VDBP-Abs) were identified in patients with T1D (n = 331) than in healthy control subjects (n = 77). Serum vitamin D levels were negatively correlated with VDBP-Ab levels in patients in whom T1D developed during the winter. Immunohistochemical localization revealed that VDBP was specifically expressed in α-cells of pancreatic islets. We propose that VDBP could be an autoantigen in T1D.

[1]  P. Bingley,et al.  Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989–2008: little short‐term influence of sunshine hours or average temperature , 2015, Pediatric diabetes.

[2]  A. Butte,et al.  The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue , 2015, Diabetologia.

[3]  Zhangli,et al.  Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk. , 2015 .

[4]  A. Butte,et al.  Anti-CD44 Antibody Treatment Lowers Hyperglycemia and Improves Insulin Resistance, Adipose Inflammation, and Hepatic Steatosis in Diet-Induced Obese Mice , 2014, Diabetes.

[5]  M. V. von Herrath,et al.  Inflammation and Hyperglycemia Mediate Deaf1 Splicing in the Pancreatic Lymph Nodes via Distinct Pathways During Type 1 Diabetes , 2014, Diabetes.

[6]  C. Fathman,et al.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis , 2014, Immunologic Research.

[7]  M. Bugliani,et al.  Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. , 2014, Endocrinology.

[8]  C. Fathman,et al.  Diminished Adenosine A1 Receptor Expression in Pancreatic α-Cells May Contribute to the Pathology of Type 1 Diabetes , 2013, Diabetes.

[9]  M. Rewers,et al.  GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes , 2013, Diabetes.

[10]  Zeng-li Zhang,et al.  Vitamin D Intake and Risk of Type 1 Diabetes: A Meta-Analysis of Observational Studies , 2013, Nutrients.

[11]  E. Bonifacio,et al.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.

[12]  E. Denkers,et al.  CCR2 and CD44 Promote Inflammatory Cell Recruitment during Fatty Liver Formation in a Lithogenic Diet Fed Mouse Model , 2013, PloS one.

[13]  C. Bortner,et al.  CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance , 2013, PloS one.

[14]  A. Steck,et al.  Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity , 2013, Diabetes Care.

[15]  P. Nickerson,et al.  Vitamin D in a Northern Canadian First Nation Population: Dietary Intake, Serum Concentrations and Functional Gene Polymorphisms , 2012, PloS one.

[16]  S. Mohr,et al.  Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case–control study , 2012, Diabetologia.

[17]  R. Chun New perspectives on the vitamin D binding protein , 2012, Cell biochemistry and function.

[18]  Alexander A. Morgan,et al.  Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes , 2012, Proceedings of the National Academy of Sciences.

[19]  M. Peakman,et al.  Antigen targets of type 1 diabetes autoimmunity. , 2012, Cold Spring Harbor perspectives in medicine.

[20]  M. Rewers,et al.  Distinguishing Persistent Insulin Autoantibodies With Differential Risk , 2011, Diabetes.

[21]  C. Forsblom,et al.  Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study , 2011, BMJ : British Medical Journal.

[22]  T. Spector,et al.  Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes , 2011, Diabetes.

[23]  Nichole Reisdorph,et al.  Chromogranin A is an autoantigen in type 1 diabetes , 2010, Nature Immunology.

[24]  R. Goswami,et al.  Interaction of Vitamin D Receptor with HLA DRB1*0301 in Type 1 Diabetes Patients from North India , 2009, PloS one.

[25]  S. Turley,et al.  Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes , 2009, Nature Immunology.

[26]  Atul J Butte,et al.  Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. , 2008, Clinical immunology.

[27]  J. Kouba,et al.  Vitamin D and Diabetes , 2008, The Diabetes educator.

[28]  A. Butte,et al.  AILUN: reannotating gene expression data automatically , 2007, Nature Methods.

[29]  Marian Rewers,et al.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.

[30]  G. Dahlquist,et al.  Worldwide childhood type 1 diabetes incidence – what can we learn from epidemiology? , 2007, Pediatric diabetes.

[31]  L. Nyström,et al.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.

[32]  M. Speeckaert,et al.  Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[33]  M. Holick Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.

[34]  L. Edelstein-Keshet,et al.  Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide , 2005, Nature Medicine.

[35]  E. Wilander,et al.  Cellular Expression and Specific Intragranular Localization of Chromogranin A, Chromogranin B, and Synaptophysin During Ontogeny of Pancreatic Islet Cells: An Ultrastructural Study , 2003, Pancreas.

[36]  Mark S. Anderson,et al.  Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.

[37]  A. Orth,et al.  Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Norris Can the sunshine vitamin shed light on type 1 diabetes? , 2001, The Lancet.

[39]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[40]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[41]  V. Gersuk,et al.  Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes1 , 2001, The Journal of Immunology.

[42]  S. Arden,et al.  Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. , 1996, The Journal of clinical investigation.

[43]  M. Christie,et al.  Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). , 1995, The Journal of clinical investigation.

[44]  S. Martin,et al.  Autoantibodies to the islet antigen ICA 69 occur in IDDM and in rheumatoid arthritis , 1995, Diabetologia.

[45]  R. Tisch,et al.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.

[46]  Bart O. Roep,et al.  T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins , 1990, Nature.

[47]  J. Palmer,et al.  Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.

[48]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[49]  Graham-Stewart Cw TERMINATION OF PREGNANCY ON PSYCHIATRIC GROUNDS. , 1964 .

[50]  M. Rewers,et al.  Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk. , 2015, Diabetes technology & therapeutics.

[51]  J. Shaw,et al.  Glycemic control and excess mortality in type 1 diabetes. , 2015, The New England journal of medicine.

[52]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[53]  W. Böcker,et al.  Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells , 2004, Virchows Archiv.

[54]  C. Beaufort The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus , 1999 .

[55]  V. Kadirkamanathan Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus , 1999, Diabetologia.

[56]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.